These contaminants may not affect potency directly, but they can cause side effects that mask or complicate the medication response
Unlike semaglutide or tirzepatide , this compound activates three receptor pathways simultaneously, targeting GLP-1, GIP, and glucagon receptors in a single molecule
The study was published in 2025, but reported data from 2022-2023
Patients using compounded products should receive explicit written instructions from their healthcare provider and pharmacist, including the exact volume or units to administer based on the specific concentration dispensed
Their blood sugar effects are substantial: Semaglutide: Reduces A1c by 1.5-1.8% from baseline (Ozempic trials) Tirzepatide: Reduces A1c by 2.0-2.3% from baseline (SURPASS trials)
These syringes come in different sizes: 30-unit (0.3ml), 50-unit (0.5ml), and 100-unit (1.0ml)